Lilly(Eli) & Co [LLY] stock is trading at $762.66, up 1.13%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The LLY shares have gain 3.85% over the last week, with a monthly amount glided 0.64%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 10, March 2024, More than two-thirds of people with atopic dermatitis and skin of color experienced skin improvement in a first-of-its-kind lebrikizumab study. In a post published today on Yahoo Finance, Eli Lilly and Company (NYSE: LLY) announced results from a first-of-its-kind study of lebrikizumab specifically designed for people with skin of color and moderate-to-severe atopic dermatitis, commonly called eczema. In this study, treatment with lebrikizumab, an investigational medicine, showed improvement in skin clearance and itch relief. These late-breaking results from a Phase 3 study are being presented today at the American Academy of Dermatology (AAD) Annual Meeting.
From an analyst’s perspective:
Lilly(Eli) & Co [NYSE: LLY] stock has seen the most recent analyst activity on February 21, 2024, when DZ Bank downgraded its rating to a Hold but kept the price target unchanged to $820 for it. Previously, Morgan Stanley reaffirmed its Overweight rating on February 16, 2024, and elevated its price target to $950. On December 21, 2023, downgrade downgraded it’s rating to Outperform and revised its price target to $610 on the stock. Deutsche Bank started tracking the stock assigning a Hold rating and suggested a price target of $535 on November 09, 2023. Jefferies upgraded its rating to Buy for this stock on August 09, 2023, and upped its price target to $615. In a note dated July 26, 2023, Citigroup reiterated an Buy rating on this stock and boosted its target price from $360 to $525.
Lilly(Eli) & Co [LLY] stock has fluctuated between $323.26 and $800.78 over the past year. Currently, Wall Street analysts expect the stock to reach $421.78 within the next 12 months. Lilly(Eli) & Co [NYSE: LLY] shares were valued at $762.66 at the most recent close of the market. An investor can expect a potential drop of -44.7% based on the average LLY price forecast.
Analyzing the LLY fundamentals
Lilly(Eli) & Co [NYSE:LLY] reported sales of 34.12B for the trailing twelve months, which represents a growth of 28.10%. Gross Profit Margin for this corporation currently stands at 0.8% with Operating Profit Margin at 0.21%, Pretax Profit Margin comes in at 0.19%, and Net Profit Margin reading is 0.15%. To continue investigating profitability, this company’s Return on Assets is posted at 0.08, Equity is 0.47 and Total Capital is 0.19. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 2.34.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 757.38 points at the first support level, and at 752.10 for the second support level. However, for the 1st resistance point, the stock is sitting at 768.81, and for the 2nd resistance point, it is at 774.96.
Lilly(Eli) & Co [LLY] reported earnings per share of $2.2 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $1.96/share, meaning a difference of $0.24 and a surprise factor of 12.20%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $0.1 per share as compared to estimates of -$0.13 per share, a difference of $0.23 representing a surprise of 176.90%.
Ratios To Look Out For
For context, Lilly(Eli) & Co’s Current Ratio is 0.94. In addition, the Quick Ratio stands at 0.73 and the Cash Ratio stands at 0.1. Considering the valuation of this stock, the price to sales ratio is 21.25, the price to book ratio is 67.22 and price to earnings (TTM) ratio is 134.16.
Transactions by insiders
Recent insider trading involved Zakrowski Donald A, SVP, Finance, & CAO, that happened on Mar 11 ’24 when 750.0 shares were sold. 10% Owner, LILLY ENDOWMENT INC completed a deal on Feb 16 ’24 to sell 0.17 million shares. Meanwhile, 10% Owner LILLY ENDOWMENT INC sold 50316.0 shares on Feb 15 ’24.
